SuspendedNot Applicable

Augmenting Virtual Reality Exposure Therapy for Acrophobia

Stopped: temporarily suspended recruitment due to COVID-related social distancing requirements

United States128 participantsStarted 2019-04-10

Plain-language summary

This study will examine whether tactile feedback and point-based rewards can be used to improve outcomes from virtual reality exposure therapy for acrophobia.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Fluent in English * Indicates sufficient fear of heights based on responses (a) on a self-report questionnaire (the Acrophobia Questionnaire) administered at prescreening, and (b) on Behavioral Avoidance Tests administered at baseline. Exclusion Criteria: * Already receiving exposure therapy for height phobia

What they're measuring

Behavioral approach test (BAT)- generalization context

Timeframe: Change from baseline to one-month follow-up

Behavioral approach test (BAT) -treatment context

Timeframe: Change from baseline to one-month follow-up

Acrophobia Questionnaire (AQ)

Timeframe: Change from baseline to one-month follow-up

Heights Interpretation Questionnaire (HIQ)

Timeframe: Change from baseline to one-month follow-up

Trial details

NCT IDNCT03917433

SponsorUniversity of Nevada, Reno

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-01-01

View on ClinicalTrials.gov More Specific Phobia trials